Allergan's Bid To Block Imprimis Drug Sales Limited To Calif.
A California federal court on Thursday handed a partial win to Allergan USA Inc. by blocking the compound drugmaker Imprimis Pharmaceuticals from selling medications under certain conditions, though the judge limited...To view the full article, register now.
Already a subscriber? Click here to view full article